Event

Journal Club - Sample Size Re-Estimation Techniques

Add to:

Joint PSI Pharmaceutical Statistics & DIA Statistics Community

DIA Chair: Tad Archambault, Principal, Virtu Stat, Ltd.

Speaker: Daniel Wachtlin, Interdisciplinary Centre for Clinical Trials (IZKS), University Medical Centre Mainz
Blinded Sample Size Recalculation in Longitudinal Clinical Trials Using Generalized Estimating Equations
Daniel Wachtlin and Meinhard Kieser
Therapeutic Innovation & Regulatory Science, Vol. 47, Issue 4, pp. 460-467, 2013
Abstract | Paper+ | Slides
 
 
PSI Chair: Byron Jones, NOVARTIS

Speaker: Andrew Hartley, PPD
Adaptive blinded sample size adjustment for comparing two normal means—a mostly Bayesian approach
Andrew M. Hartley
Pharmaceutical Statistics, Vol. 11, Issue 3, pp. 230-240, 2012
Abstract | Paper+ | Slides
 
 
Discussant: Peiling Yang, Statistical Team Leader, Division of Biometrics I, US FDA
Slides

+ Papers available to view from October 22nd 2013 to November 5th 2013.

For a flier advertising the event, please click here.

To access the recording, please visit the Video-on-Demand Library.
 

Upcoming Events

Joint PSI, EFSPI & ASA BIOP Webinar: Estimands

PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.

PSI Journal Club: Bayesian Methods

Please join us to hear Jingjing Ye (BeiGene) and Amy LaLonde (Eli Lilly) present their recent work. The webinar will be chaired by Bruno Boulanger (PharmaLex).

Latest Jobs

Senior Principal / Principal Biostatistician

Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.

Statisticians - Oncology

Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.

Therapeutic Area Global Expert Statistician - CNS & Retinopathies

You are looking for a new professional challenge - we offer you this interesting position in a global company that has been awarded several times the status of best employer.